StockMacro
Menu

Steris

$255.76 +18% in 6 monthsMarket cap $24.8B

STE on XNYS, Health Care, STERIS plc, job postings

Measures activity, not value. Not investment advice.

Shares jumped 15% in a month while profit rose 20% to $826.9M over 12 months.

  • GoodLatest quarter revenue rose 8.8% to $1.6B
  • WatchOne restructuring filing in the last 90 days

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Industry
Orthopedic, prosthetic & surgical appliances & supplies (Health Care)
Employees
17,937
Website
steris.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 3 Feb 2027 (an estimate: a year ago it reported on 4 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.6B, net income $213.7M.
Quarter to 31 Dec 2021: revenue $1.2B, net income $143.6MQuarter to 31 Dec 2021: revenue $1.2B, net income $143.6MQuarter to 31 Mar 2022: revenue $1.2B, net income $52.3MQuarter to 31 Mar 2022: revenue $1.2B, net income $52.3MQuarter to 30 Jun 2022: revenue $1.2B, net income $111.3MQuarter to 30 Jun 2022: revenue $1.2B, net income $111.3MQuarter to 30 Sep 2022: revenue $1.2B, net income -$315.3MQuarter to 30 Sep 2022: revenue $1.2B, net income -$315.3MQuarter to 31 Dec 2022: revenue $1.2B, net income $123.8MQuarter to 31 Dec 2022: revenue $1.2B, net income $123.8MQuarter to 31 Mar 2023: revenue $1.3B, net income $187.2MQuarter to 31 Mar 2023: revenue $1.3B, net income $187.2MQuarter to 30 Jun 2023: revenue $1.3B, net income $123.6MQuarter to 30 Jun 2023: revenue $1.3B, net income $123.6MQuarter to 30 Sep 2023: revenue $1.3B, net income $115.3MQuarter to 30 Sep 2023: revenue $1.3B, net income $115.3MQuarter to 31 Dec 2023: revenue $1.4B, net income $140.7MQuarter to 31 Dec 2023: revenue $1.4B, net income $140.7MQuarter to 31 Mar 2024: revenue $1.4B, net income -$1.4MQuarter to 31 Mar 2024: revenue $1.4B, net income -$1.4MQuarter to 30 Jun 2024: revenue $1.3B, net income $145.4MQuarter to 30 Jun 2024: revenue $1.3B, net income $145.4MQuarter to 30 Sep 2024: revenue $1.3B, net income $150.0MQuarter to 30 Sep 2024: revenue $1.3B, net income $150.0MQuarter to 31 Dec 2024: revenue $1.4B, net income $173.5MQuarter to 31 Dec 2024: revenue $1.4B, net income $173.5MQuarter to 31 Mar 2025: revenue –, net income $145.7MQuarter to 30 Jun 2025: revenue $1.4B, net income $177.4MQuarter to 30 Jun 2025: revenue $1.4B, net income $177.4MQuarter to 30 Sep 2025: revenue $1.5B, net income $191.9MQuarter to 30 Sep 2025: revenue $1.5B, net income $191.9MQuarter to 31 Dec 2025: revenue $1.5B, net income $192.9MQuarter to 31 Dec 2025: revenue $1.5B, net income $192.9MQuarter to 31 Mar 2026: revenue $1.6B, net income $220.2MQuarter to 31 Mar 2026: revenue $1.6B, net income $220.2MQuarter to 30 Jun 2026: revenue $1.5B, net income $200.1MQuarter to 30 Jun 2026: revenue $1.5B, net income $200.1MQuarter to 30 Sep 2026: revenue $1.6B, net income $213.7MQuarter to 30 Sep 2026: revenue $1.6B, net income $213.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $1.6B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.6B$213.7M
30 Jun 2026$1.5B$200.1M
31 Mar 2026$1.6B$220.2M
31 Dec 2025$1.5B$192.9M
30 Sep 2025$1.5B$191.9M
30 Jun 2025$1.4B$177.4M
31 Mar 2025–$145.7M
31 Dec 2024$1.4B$173.5M
30 Sep 2024$1.3B$150.0M
30 Jun 2024$1.3B$145.4M
31 Mar 2024$1.4B-$1.4M
31 Dec 2023$1.4B$140.7M
30 Sep 2023$1.3B$115.3M
30 Jun 2023$1.3B$123.6M
31 Mar 2023$1.3B$187.2M
31 Dec 2022$1.2B$123.8M
30 Sep 2022$1.2B-$315.3M
30 Jun 2022$1.2B$111.3M
31 Mar 2022$1.2B$52.3M
31 Dec 2021$1.2B$143.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $6.2B $5.7B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +8.1% +8.1%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $826.9M $688.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 44.6% 44.3% 61.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 19.0% 17.1% 5.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 13.4% 12.1% -2.7%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 11.6% -20.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $937.2M $961.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $531.1M $319.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.9B $1.9B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $1.4B $1.6B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.26 0.22
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $74.74
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 30.0 27.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 4.0 2.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 4.2 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.4 3.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
SterisSTE (this company) $24.8B30.04.0+8.1%13.4%
Zimmer BiometZBH $19.1B24.92.2+7.0%9.0%
Align TechnologyALGN $10.9B22.22.6+4.6%11.7%
Edwards LifesciencesEW $58.6B57.38.8+13%15.3%
Mine SafetyMSA $6.5B21.63.3+8.1%15.0%
Intuitive SurgicalISRG $138.3B46.811.0+21%23.5%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$3.3M

bought $0, sold $3.3M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.9%

811 13F filers vs 818

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

98%

94.9M shares held by 13F filers (30 Sep 2026) of 97.1M outstanding (3 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.2%

2.2M shares sold short (30 Oct 2026) of 97.1M outstanding (3 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.9

2.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-9.0%

2.4M shares sold short in the report before, 2.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

61%

61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

655

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-28%

18 vs 25 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+8.8%

$1.6B vs $1.5B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-12%

$76.1M vs $86.5M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$41.5M

the 12 months before: $38.5M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$100K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

11

11 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.5×

11 articles in the last 7 days; its usual week has 2.

Price $255.76 on 20 Nov 2026, -0.5% over 12 months (12-month range $199.40 to $268.65)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $6.5M in the last 12 months (the 12 months before: -$19.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 18 published in the last 12 months, -28% on the 12 months before.
Revenue per quarter. Revenue $1.6B in the latest quarter, +8.8% on a year earlier.
Capital spending per quarter. Capital spending $76.1M in the latest quarter, -12% on a year earlier.
Institutional holders (13F filers). 811 13F filers reported holding it in the latest 13F quarter, +1.5% on a year earlier.
Federal obligations. Federal obligations: $50.1M published in the last 12 months, +44% on the 12 months before.
Lobbying spend. Lobbying spend: $100K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
4 Nov 20268-K and other filingsA major agreement ended
4 Nov 20268-K and other filingsRestructuring costs announced
5 Aug 20268-K and other filingsRestructuring costs announced
7 May 20268-K and other filingsDirector or officer change
6 Apr 20268-K and other filingsDirector or officer change
6 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Mar 2026Sharp changeShort interest spike: short interest spike, 1.8M vs usual 1.0M (2026-02-13); 1.9x the same period a year earlier
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 86 vs usual 60 (2025-09-30); 1.3x the same period a year earlier
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 103 vs usual 60 (2025-06-30); 1.8x the same period a year earlier
6 Aug 20258-K and other filingsDirector or officer change
3 Jul 20258-K and other filingsDirector or officer change
3 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Jun 2024Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of Health and Human Services): STERIS CORPORATION: new Department of Health and Human Services contract 75H71024F80277 ($1,162,562)
8 May 20248-K and other filingsRestructuring costs announced
3 May 20238-K and other filingsDirector or officer change
3 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Aug 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 115.9M vs usual 70.0M (2022-06-30); 2.1x the same period a year earlier
15 Feb 2022Sharp changeQuarterly revenue change: quarterly revenue change, 1.2B vs usual 816.0M (2021-12-31); 1.5x the same period a year earlier
Insider net buying (open market)
Month from 1 Dec 2021: -$7.2M published
Month from 1 Feb 2022: -$1.8M published
Month from 1 Apr 2022: -$5.0M published
Month from 1 Jun 2022: -$546K published
Month from 1 Dec 2022: -$308K published
Month from 1 Mar 2023: -$219K published
Month from 1 May 2023: -$5.0M published
Month from 1 May 2024: -$11.0M published
Month from 1 Jun 2024: -$2.0M published
Month from 1 Aug 2024: -$113K published
Month from 1 Sep 2024: -$11.5M published
Month from 1 Nov 2024: -$366K published
Month from 1 May 2025: -$3.2M published
Month from 1 Jun 2025: -$4.8M published
Month from 1 Aug 2025: -$4.5M published
Month from 1 Oct 2025: -$38K published
Month from 1 Nov 2025: -$6.6M published
Month from 1 Mar 2026: -$735K published
Month from 1 Jun 2026: -$1.6M published
Month from 1 Aug 2026: -$957K published
Month from 1 Nov 2026: -$3.3M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 4 published
Quarter from 1 Apr 2022: 3 published
Quarter from 1 Jul 2022: 9 published
Quarter from 1 Oct 2022: 8 published
Quarter from 1 Jan 2023: 5 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 3 published
Quarter from 1 Oct 2023: 5 published
Quarter from 1 Jan 2024: 4 published
Quarter from 1 Apr 2024: 8 published
Quarter from 1 Jul 2024: 8 published
Quarter from 1 Oct 2024: 7 published
Quarter from 1 Jan 2025: 5 published
Quarter from 1 Apr 2025: 4 published
Quarter from 1 Jul 2025: 8 published
Quarter from 1 Oct 2025: 8 published
Quarter from 1 Jan 2026: 4 published
Quarter from 1 Apr 2026: 3 published
Quarter from 1 Jul 2026: 8 published
Quarter from 1 Oct 2026: 3 published
Revenue per quarter
Quarter ended 31 Dec 2021: $1.2B, +49% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $1.2B, +39% on a year earlier; public on 1 Jun 2022
Quarter ended 30 Jun 2022: $1.2B, +19% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $1.2B, +0.3% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $1.2B, +0.6% on a year earlier; public on 9 Feb 2023
Quarter ended 31 Mar 2023: $1.3B, +5.8% on a year earlier; public on 30 May 2024
Quarter ended 30 Jun 2023: $1.3B, +11% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.3B, +12% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.4B, +15% on a year earlier; public on 9 Feb 2024
Quarter ended 31 Mar 2024: $1.4B, +11% on a year earlier; public on 30 May 2024
Quarter ended 30 Jun 2024: $1.3B, -0.4% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $1.3B, -1.0% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $1.4B, -1.8% on a year earlier; public on 8 Feb 2025
Quarter ended 30 Jun 2025: $1.4B, +8.7% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $1.5B, +9.9% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $1.5B, +9.2% on a year earlier; public on 7 Feb 2026
Quarter ended 31 Mar 2026: $1.6B; public on 30 May 2026
Quarter ended 30 Jun 2026: $1.5B, +7.3% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $1.6B, +8.8% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $81.1M, +51% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $73.1M, -2.3% on a year earlier; public on 1 Jun 2022
Quarter ended 30 Jun 2022: $115.9M, +106% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $82.8M, +7.5% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $91.8M, +13% on a year earlier; public on 9 Feb 2023
Quarter ended 31 Mar 2023: $71.4M, -2.2% on a year earlier; public on 27 May 2023
Quarter ended 30 Jun 2023: $66.6M, -43% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $83.3M, +0.6% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $118.9M, +30% on a year earlier; public on 9 Feb 2024
Quarter ended 31 Mar 2024: $91.5M, +28% on a year earlier; public on 30 May 2024
Quarter ended 30 Jun 2024: $108.1M, +62% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $101.9M, +22% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $89.2M, -25% on a year earlier; public on 8 Feb 2025
Quarter ended 31 Mar 2025: $70.9M, -23% on a year earlier; public on 30 May 2025
Quarter ended 30 Jun 2025: $93.6M, -13% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $86.5M, -15% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $98.7M, +11% on a year earlier; public on 7 Feb 2026
Quarter ended 31 Mar 2026: $90.2M, +27% on a year earlier; public on 30 May 2026
Quarter ended 30 Jun 2026: $87.5M, -6.5% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $76.1M, -12% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 574; public on 14 Feb 2022
31 Mar 2022 report: 604; public on 16 May 2022
30 Jun 2022 report: 623; public on 15 Aug 2022
30 Sep 2022 report: 577; public on 14 Nov 2022
31 Dec 2022 report: 586; public on 14 Feb 2023
31 Mar 2023 report: 572; public on 15 May 2023
30 Jun 2023 report: 605; public on 14 Aug 2023
30 Sep 2023 report: 634; public on 14 Nov 2023
31 Dec 2023 report: 654; public on 14 Feb 2024
31 Mar 2024 report: 692; public on 15 May 2024
30 Jun 2024 report: 716; public on 14 Aug 2024
30 Sep 2024 report: 714; public on 14 Nov 2024
31 Dec 2024 report: 735; public on 14 Feb 2025
31 Mar 2025 report: 742; public on 15 May 2025
30 Jun 2025 report: 802; public on 14 Aug 2025
30 Sep 2025 report: 799; public on 14 Nov 2025
31 Dec 2025 report: 857; public on 17 Feb 2026
31 Mar 2026 report: 821; public on 15 May 2026
30 Jun 2026 report: 818; public on 14 Aug 2026
30 Sep 2026 report: 811; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $1.9M published
Month from 1 Dec 2021: $7.9M published
Month from 1 Jan 2022: $2.9M published
Month from 1 Feb 2022: $1.9M published
Month from 1 Mar 2022: $3.0M published
Month from 1 Apr 2022: $1.9M published
Month from 1 May 2022: $2.2M published
Month from 1 Jun 2022: $2.3M published
Month from 1 Jul 2022: $3.2M published
Month from 1 Aug 2022: $4.6M published
Month from 1 Sep 2022: $3.6M published
Month from 1 Oct 2022: $2.8M published
Month from 1 Nov 2022: $4.3M published
Month from 1 Dec 2022: $10.6M published
Month from 1 Jan 2023: $3.7M published
Month from 1 Feb 2023: $1.6M published
Month from 1 Mar 2023: $2.6M published
Month from 1 Apr 2023: $944K published
Month from 1 May 2023: $3.4M published
Month from 1 Jun 2023: $2.2M published
Month from 1 Jul 2023: $7.7M published
Month from 1 Aug 2023: $2.1M published
Month from 1 Sep 2023: $3.0M published
Month from 1 Oct 2023: $4.9M published
Month from 1 Nov 2023: $4.6M published
Month from 1 Dec 2023: $7.4M published
Month from 1 Jan 2024: $2.6M published
Month from 1 Feb 2024: $1.5M published
Month from 1 Mar 2024: $3.0M published
Month from 1 Apr 2024: $2.4M published
Month from 1 May 2024: $3.9M published
Month from 1 Jun 2024: $1.9M published
Month from 1 Jul 2024: $3.1M published
Month from 1 Aug 2024: $5.8M published
Month from 1 Sep 2024: $1.5M published
Month from 1 Oct 2024: $9.1M published
Month from 1 Nov 2024: $4.2M published
Month from 1 Dec 2024: $4.2M published
Month from 1 Jan 2025: $2.4M published
Month from 1 Feb 2025: $79K published
Month from 1 Mar 2025: $2.0M published
Month from 1 Apr 2025: $2.1M published
Month from 1 May 2025: $3.4M published
Month from 1 Jun 2025: $2.7M published
Month from 1 Jul 2025: $1.4M published
Month from 1 Aug 2025: $957K published
Month from 1 Sep 2025: $2.2M published
Month from 1 Oct 2025: $9.3M published
Month from 1 Nov 2025: $3.9M published
Month from 1 Dec 2025: $5.2M published
Month from 1 Jan 2026: $4.3M published
Month from 1 Feb 2026: $1.2M published
Month from 1 Mar 2026: $909K published
Month from 1 Apr 2026: $1.9M published
Month from 1 May 2026: $4.9M published
Month from 1 Jun 2026: $3.2M published
Month from 1 Jul 2026: $5.2M published
Month from 1 Aug 2026: $6.9M published
Month from 1 Sep 2026: $7.6M published
Month from 1 Oct 2026: $7.7M published
Month from 1 Nov 2026: $941K published
Lobbying spend
Quarter from 1 Oct 2026: $100K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is capital expenditure, quarter at $76.1M (30 Sep 2026), 15% below its normal quarter of $89.7M; higher than 50% of its own history.
  • Insider net buying (open market): Insiders sold a net $6.5M in the last 12 months (the 12 months before: -$19.1M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 18 published in the last 12 months, -28% on the 12 months before.
  • Revenue per quarter: Revenue $1.6B in the latest quarter, +8.8% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 3 sales, $3.3M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Nov 2026Julia MadsenSr. VP and GM, Life SciencesSell2,046$260.00$532KForm 4
12 Nov 2026Karen L BurtonSr. Vice Pres., CFOSellafter exercising options5,880$255.62$1.5MForm 4
12 Nov 2026Mohsen SohiDirectorSellafter exercising options4,893$253.22$1.2MForm 4
12 Aug 2026Mohsen SohiDirectorSellafter exercising options4,058$235.78$957KForm 4
16 Jun 2026John Adam ZangerleSr. VP, Gen Counsel, and Sec.Sellplanned in advance (10b5-1)1,419$209.28$297KForm 4
8 Jun 2026Daniel A CarestioPresident and CEOSellplanned in advance (10b5-1)4,428$213.82$947KForm 4
4 Jun 2026Richard C BreedenDirectorSellafter exercising options1,481$209.51$310KForm 4
6 Mar 2026Cynthia L FeldmannDirectorSellafter exercising options3,098$237.21$735KForm 4

811 institutions reported shares at the end of Q3 2026, 98% of the shares outstanding; 79 opened a position, 85 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.9.8M10.1%$2.1B+1.0M+11%
Vanguard Capital Management LLC6.4M6.57%$1.3B-29K-0.4%
State Street Corp5.2M5.34%$1.1B+108K+2.1%
Vanguard Portfolio Management LLC4.9M5.10%$1.0B-52K-1.0%
Massachusetts Financial Services Co3.8M3.93%$846.7M+11K+0.3%
Morgan Stanley3.6M3.76%$765.9M-303K-7.7%
Wellington Management Group LLP3.4M3.53%$719.3M-78K-2.2%
Orbis Allan Gray Ltd3.1M3.16%$643.8M+388K+14%
Geode Capital Management, LLC2.7M2.73%$554.5M+35K+1.3%
Mitsubishi UFJ Asset Management Co., Ltd.2.2M2.24%$457.4M-22K-1.0%

Federal contracts

All 27 federal contracts

3 new awards in 12 months, $4.4M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
13 Aug 2026Department of Veterans Affairs$1.6MSTERIS EQUIPMENT MAINTENANCE SERVICE IDIQ FOR VISN 23 EO 14398USAspending
21 Jul 2026Department of Veterans Affairs$1.6MSPS TRAILER RENTALUSAspending
11 Feb 2026Department of Veterans Affairs$1.2MSPS-STERIS CART WASHER DISINFECTOR/ STERILIZER/ PREVACUUMUSAspending
29 Aug 2025Department of Veterans Affairs$1.5MTASK ORDER FOR STERIS EQUIPMENT MAINTENANCE SERVICE FOR VISN 23USAspending
1 Jul 2025Department of Veterans Affairs$3.0Mup to $13.1MSPS STERIS TRAILER LEASE, KCUSAspending
7 Feb 2025Department of Veterans Affairs$2.1Mup to $5.6MSPS EQUIPMENT PM&R -STERILIZER TRAILER | MOBILE SPD FACILITY FOR THE LEBANON VAMCUSAspending
19 Jul 2024Department of Veterans Affairs$1.4MSPS EQUIPMENTUSAspending
12 Jun 2024Department of Health and Human ServicesIndian Health Service$1.2MRENTAL OF MOBILE STERILE PROCESSING UNITUSAspending

Company events

All 27 company events

In 12 months: 2 director or officer changes, 2 restructurings, 2 major agreements, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Nov 2026Restructuring costs announced8-K
4 Nov 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
13 Oct 2026Signed a major agreement8-K
5 Aug 2026Restructuring costs announced8-K
7 May 2026Director or officer change8-K
6 Apr 2026Director or officer change8-K
6 Aug 2025Director or officer changeSame filing: shareholder vote results8-K
3 Jul 2025Director or officer change8-K

655 open postings; careers site tracked since 21 Nov 2026. Most in Field service & installation 20%, Manufacturing & production 16%, Supply chain & procurement 10%, Sales & business development 6%.

PostedJobLocation
21 Nov 2026Equipment Service TechnicianField service & installationBend, Oregon, United States
20 Nov 2026InstallerField service & installationTruro, Nova Scotia, Canada
20 Nov 2026Mechanical DesignerMechanical engineeringQuébec, Quebec, Canada
20 Nov 2026Welder IIManufacturing & productionMentor, Ohio, United States
20 Nov 2026IT Site ManagerCorporate ITQuebec, Quebec, Canada
20 Nov 2026InstallerField service & installationHalifax, Nova Scotia, Canada
20 Nov 2026Laboratory Technician IResearch & scienceTullamore, Offaly, Ireland
20 Nov 2026Equipment Service TechnicianField service & installationAbitibi, Quebec, Canada

Reported lobbying spend: $100K in Q3 2026, $120K in Q3 2021. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Mar 2021NewThorn Run Partnersfor Steris CorporationDevice Servicing Act; Issues related to the medical device industry.Health issuesFiling
30 Apr 2020EndedHurt, Norton & Associates, Inc.for Steris CorporationExecutive and Legislative Branch initiatives relating to FDA regulation of medical devices and services, taxes and fees relative to medical devices and services, revisions in health care lawsHealth issuesFiling
20 Mar 2020NewJeffrey J. Kimbell & Associates, Inc.for Steris CorporationIssues related to tax provisions in HR 748, the Coronavirus Aid, Relief, and Economic Security (CARES) ActTaxationFiling
1 Jul 2019NewSteris Corporationits own lobbyistsUSMCA, Medical Device Tax, MDUFA, Appropriations, TCJAHealth issues, Manufacturing, Taxation, Budget, TradeFiling
31 Dec 2016EndedMcdonald Hopkins Government Strategies, LLCfor Steris CorporationNo lobbying activity; Monitor tax reform issues, generallyDefense, Taxation, Budget, Government issuesFiling
25 Nov 2013NewMcdonald Hopkins Government Strategies, LLCfor Steris CorporationDefense decontamination related issues and initiatives. Joint Strike Fighter program related issues.Defense, BudgetFiling
15 Mar 2013EndedThe CJR Group, Inc.for Steris CorporationBiomedical issuesMEDFiling
20 May 2011NewThe CJR Group, Inc.for Steris CorporationIssues related to health and sterilizationHealth issues, MEDFiling

The 5 newest of 142 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

9 Nov 2021confirmed

Confirmed across sources Filings + Financials and Lobbying

Steris (STE): lobbying on a new issue, while it reported revenue of $1.2B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year. Two unrelated kinds of activity within 15 days.

  • Lobbying: Lobbying on a new issue, became public on 25 Oct 2021
  • Financials: Quarterly revenue change, became public on 9 Nov 2021
2019-09-30: $736.8M2019-12-31: $774.3M2020-03-31: $823.0M2020-06-30: $668.9M2020-09-30: $756.1M2020-12-31: $808.9M2021-03-31: $873.5M2021-06-30: $968.4M2021-09-30: $1.2B
The quarter ended 30 Sep 2021 against the 8 quarters before it. this quarterearliernormal: $791.6M
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 25 Oct 2021

Steris lobbying on a new issue.

New
['DIS']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12724444

Financials: Quarterly revenue change became public on 9 Nov 2021

Steris reported revenue of $1.2B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year.

This period
$1.2B (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$791.6M
Typical spread (median absolute deviation)
$45.1M
How far from its usual level
+5.1
Same quarter last year
$756.1M
History used
1,553 days
2019-09-30: $736.8M2019-12-31: $774.3M2020-03-31: $823.0M2020-06-30: $668.9M2020-09-30: $756.1M2020-12-31: $808.9M2021-03-31: $873.5M2021-06-30: $968.4M2021-09-30: $1.2B
the quarter ended 30 Sep 20218 earlier quartersnormal: $791.6M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 Jul 2020confirmed

Confirmed across sources Government contracts and Lobbying

Steris (STE): won its first award from the Department of Defense, a $1.1M contract, after 5 earlier federal awards from other agencies, while it lobbying on a new issue. Two unrelated kinds of activity on the same day.

  • Government contracts: First award from a new federal agency, became public on 21 Jul 2020
  • Lobbying: Lobbying on a new issue, became public on 21 Jul 2020
See the evidence (2 changes)

Government contracts: First award from a new federal agency became public on 21 Jul 2020

Steris won its first award from the Department of Defense, a $1.1M contract, after 5 earlier federal awards from other agencies.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
5

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Lobbying: Lobbying on a new issue became public on 21 Jul 2020

Steris lobbying on a new issue.

New
['ENV']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12720388

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 4 Nov 2026Filings record

    A major agreement ended

  2. 4 Nov 2026Filings record

    Restructuring costs announced

  3. 19 Aug 2026Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26326N0657 ($1.6M) (dated 13 Aug 2026)

  4. 5 Aug 2026Filings record

    Restructuring costs announced

  5. 27 Jul 2026Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26226P1240 ($1.6M) (dated 21 Jul 2026)

  6. 7 May 2026Filings record

    Director or officer change

  7. 6 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 6 Apr 2026Filings record

    Director or officer change

  9. 26 Feb 2026Short interest and volume change

    had 1.8M shares sold short in the 13 Feb 2026 report, 1.9× the same report last year.

    Same report last year: 929K; its normal report is 1.0M.

    See the evidence
    This period
    1.8M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    135K
    How far from its usual level
    +3.8
    Same report last year
    929K
    History used
    2,968 days
    2025-02-14: 929K2025-02-28: 1.0M2025-03-14: 1.2M2025-03-31: 1.1M2025-04-15: 1.5M2025-04-30: 1.3M2025-05-15: 1.1M2025-05-30: 900K2025-06-13: 728K2025-06-30: 819K2025-07-15: 847K2025-07-31: 988K2025-08-15: 907K2025-08-29: 808K2025-09-15: 1.1M2025-09-30: 1.1M2025-10-15: 956K2025-10-31: 959K2025-11-14: 922K2025-11-28: 1.2M2025-12-15: 1.4M2025-12-31: 1.4M2026-01-15: 1.3M2026-01-30: 1.6M2026-02-13: 1.8M
    the 13 Feb 2026 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 17 Feb 2026Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26226P0496 ($1.2M) (dated 11 Feb 2026)

  11. 14 Nov 2025Institutional holdings change

    saw 86 13F filers open a new position in the quarter ended 30 Sep 2025, 1.3× the same quarter last year.

    Same quarter last year: 64; its normal quarter is 60.

    See the evidence
    This period
    86 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    60
    Typical spread (median absolute deviation)
    5
    How far from its usual level
    +3.5
    Same quarter last year
    64
    History used
    4,383 days
    2023-09-30: 582023-12-31: 402024-03-31: 622024-06-30: 562024-09-30: 642024-12-31: 542025-03-31: 782025-06-30: 1032025-09-30: 86
    the quarter ended 30 Sep 20258 earlier quartersnormal: 60

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  12. 4 Sep 2025Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26325N0760 ($1.5M) (dated 29 Aug 2025)

  13. 14 Aug 2025Institutional holdings change

    saw 103 13F filers open a new position in the quarter ended 30 Jun 2025, 1.8× the same quarter last year.

    Same quarter last year: 56; its normal quarter is 60.

    See the evidence
    This period
    103 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    60
    Typical spread (median absolute deviation)
    5
    How far from its usual level
    +5.8
    Same quarter last year
    56
    History used
    4,291 days
    2023-06-30: 692023-09-30: 582023-12-31: 402024-03-31: 622024-06-30: 562024-09-30: 642024-12-31: 542025-03-31: 782025-06-30: 103
    the quarter ended 30 Jun 20258 earlier quartersnormal: 60

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  14. 6 Aug 2025Filings record

    Director or officer change

  15. 7 Jul 2025Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C25525C0035 ($3.0M) (dated 1 Jul 2025)

  16. 3 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 3 Jul 2025Filings record

    Director or officer change

  18. 15 May 2025Institutional holdings record

    Orbis Allan Gray Ltd opened a $350.0M position (2025Q1 13F)

  19. 13 Feb 2025Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C24425P0266 ($1.1M) (dated 7 Feb 2025)

  20. 25 Jul 2024Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C25724P0449 ($1.4M) (dated 19 Jul 2024)

  21. 3 Jul 2024Government contracts record

    STERIS CORPORATION: new Department of Defense contract FA860124P0052 ($1.4M) (dated 2 Apr 2024)

  22. 18 Jun 2024Government contracts change

    won its first award from the Department of Health and Human Services, a $1.2M contract, after 18 earlier federal awards from other agencies.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    18

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  23. 18 Jun 2024Government contracts record

    STERIS CORPORATION: new Department of Health and Human Services contract 75H71024F80277 ($1.2M) (dated 12 Jun 2024)

  24. 28 May 2024Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C10G24K0001 ($1.1M) (dated 22 May 2024)

  25. 8 May 2024Filings record

    Restructuring costs announced

  26. 26 Feb 2024Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26324C0024 ($1.3M) (dated 20 Feb 2024)

  27. 10 Sep 2023Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26223F0703 ($1.6M) (dated 4 Sep 2023)

  28. 3 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 3 May 2023Filings record

    Director or officer change

  30. 25 Apr 2023Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C24823F0190 ($1.9M) (dated 19 Apr 2023)

  31. 30 Dec 2022Government contracts record

    STERIS CORPORATION: new Department of Defense contract HT001422P0259 ($1.6M) (dated 29 Sep 2022)

  32. 28 Dec 2022Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C25623F0093 ($1.1M) (dated 22 Dec 2022)

  33. 28 Sep 2022Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26322N0788 ($2.0M) (dated 22 Sep 2022)

  34. 21 Sep 2022Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C26322F0112 ($1.1M) (dated 15 Sep 2022)

  35. 9 Aug 2022Financials change

    spent $115.9M on capital projects in the quarter ended 30 Jun 2022, 2.1× the same quarter last year.

    Same quarter last year: $56.4M; its normal quarter is $70.0M.

    See the evidence
    This period
    $115.9M (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    $70.0M
    Typical spread (median absolute deviation)
    $9.1M
    How far from its usual level
    +3.4
    Same quarter last year
    $56.4M
    History used
    1,461 days
    2020-06-30: $66.9M2020-09-30: $43.9M2020-12-31: $53.8M2021-03-31: $74.8M2021-06-30: $56.4M2021-09-30: $77.0M2021-12-31: $81.1M2022-03-31: $73.1M2022-06-30: $115.9M
    the quarter ended 30 Jun 20228 earlier quartersnormal: $70.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  36. 16 Jun 2022Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C25222F0208 ($1.3M) (dated 10 Jun 2022)

  37. 1 Jun 2022Government contracts record

    STERIS CORPORATION: new Department of Veterans Affairs contract 36C25522C0042 ($3.2M) (dated 26 May 2022)

  38. 15 Feb 2022Financials change

    reported revenue of $1.2B for the quarter ended 31 Dec 2021, 1.5× the same quarter last year.

    Same quarter last year: $808.9M; its normal quarter is $816.0M.

    See the evidence
    This period
    $1.2B (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $816.0M
    Typical spread (median absolute deviation)
    $58.7M
    How far from its usual level
    +4.5
    Same quarter last year
    $808.9M
    History used
    1,645 days
    2019-12-31: $774.3M2020-03-31: $823.0M2020-06-30: $668.9M2020-09-30: $756.1M2020-12-31: $808.9M2021-03-31: $873.5M2021-06-30: $968.4M2021-09-30: $1.2B2021-12-31: $1.2B
    the quarter ended 31 Dec 20218 earlier quartersnormal: $816.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  39. 9 Nov 2021several at once

    lobbying on a new issue, while it reported revenue of $1.2B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year. Two unrelated kinds of activity within 15 days.

    See the evidence (2 changes)

    Lobbying: Lobbying on a new issue became public on 25 Oct 2021

    Steris lobbying on a new issue.

    New
    ['DIS']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12724444

    Financials: Quarterly revenue change became public on 9 Nov 2021

    Steris reported revenue of $1.2B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year.

    This period
    $1.2B (the quarter ended 30 Sep 2021)
    Normal quarter (median of 8 earlier)
    $791.6M
    Typical spread (median absolute deviation)
    $45.1M
    How far from its usual level
    +5.1
    Same quarter last year
    $756.1M
    History used
    1,553 days
    2019-09-30: $736.8M2019-12-31: $774.3M2020-03-31: $823.0M2020-06-30: $668.9M2020-09-30: $756.1M2020-12-31: $808.9M2021-03-31: $873.5M2021-06-30: $968.4M2021-09-30: $1.2B
    the quarter ended 30 Sep 20218 earlier quartersnormal: $791.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  40. 9 Nov 2021Financials change

    reported revenue of $1.2B for the quarter ended 30 Sep 2021, 1.6× the same quarter last year.

    Same quarter last year: $756.1M; its normal quarter is $791.6M.

    See the evidence
    This period
    $1.2B (the quarter ended 30 Sep 2021)
    Normal quarter (median of 8 earlier)
    $791.6M
    Typical spread (median absolute deviation)
    $45.1M
    How far from its usual level
    +5.1
    Same quarter last year
    $756.1M
    History used
    1,553 days
    2019-09-30: $736.8M2019-12-31: $774.3M2020-03-31: $823.0M2020-06-30: $668.9M2020-09-30: $756.1M2020-12-31: $808.9M2021-03-31: $873.5M2021-06-30: $968.4M2021-09-30: $1.2B
    the quarter ended 30 Sep 20218 earlier quartersnormal: $791.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 88 entries; narrow the window or the kind of data to see older ones.

Not listed: 181 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001757898
Ticker
STE
Domain
steris.com
Employer name
STERIS CORPORATION (1 unverified)
Hq location
L2|DUBLIN|2 (1 unverified)
Lobbying client
steris, steris corporation through hurt norton and associates
Name
Albert Browne Limited, American Sterilizer Company, Bioster-Mottahedoon Egypt SAE, Birkova Products, LLC and 145 more
Uei
EN97KM9NNXK1, HBARYT6JY1E6, JJ1PTMC1XPR5, NL5RN24J2BF9 and 1 more
Wikidata
Q80947821
Wikipedia
Steris
  • DOL H-1B labor condition applications and PERM certifications604 data points28 Oct 2019 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)15 records, 210 data points30 Jun 2001 to 30 Sep 2026
  • SEC Form 13F institutional holdings5 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)96 records28 Mar 2019 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)713 data points31 Mar 2016 to 3 Nov 2026
  • SEC Form 4 insider transactions100 records, 308 data points16 May 2019 to 17 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards27 records, 15447 data points1 Oct 2007 to 18 Nov 2026
  • Wikipedia pageviews2513 data points4 Jan 2020 to 20 Nov 2026